A Quote by Thomas Pogge

It's easy to complain that pharmaceutical companies place profits over people and apparently care more about hair loss than TB. However, many in the pharmaceutical industry would be glad for the opportunity to reorient their research toward medicines that are truly needed, provided only that such research is financially sustainable.
Big Pharma needs sick people to prosper. Patients, not healthy people, are their customers. If everybody was cured of a particular illness or disease, pharmaceutical companies would lose 100% of their profits on the products they sell for that ailment. What all this means is because modern medicine is so heavily intertwined with the financial profits culture, it’s a sickness industry more than it is a health industry.
In the last century the practice of medicine has become no more than an adjunct to the pharmaceutical industry and the other aspects of the huge, powerful and immensely profitable health care industry. Medicine is no longer an independent profession. Doctors have become nothing more than a link connecting the pharmaceutical industry to the consumer.
Since the 1920s, virtually all continuing medical and public health education is funded by pharmaceutical companies. In fact, today, the FDA can't even tell health scientists the truth about vaccine contaminants and their likely effects. The agency is bound and gagged by proprietary laws and non-disclosure agreements forced upon them by the pharmaceutical industry. Let us not forget that the pharmaceutical industry, as a special interest group, is the number one contributor to politicians on Capital Hill.
Insurance companies, government agencies, and the pharmaceutical industry all push for mental health care that is brief, intermittent, and focused on quick fixes, despite the fact that many people struggle with emotional difficulties that can only be addressed over time using special psychodynamic skills.
Research is subordinated (not to a long-term social benefit) but to an immediate commercial profit. Currently, disease (not health) is one of the major sources of profit for the pharmaceutical industry, and the doctors are willing agents of those profits.
The pharmaceutical industry isn't the only place where there's waste and inefficiency and profiteering. That happens in much of the rest of the health care industry.
The pharmaceutical industry likes to depict itself as a research-based industry, as the source of innovative drugs. Nothing could be further from the truth. This is their incredible PR and their nerve.
These pharmaceutical company executives are dope dealers and they should be treated worse, and more roughly than dope dealers. When you're talking about millionaire and billionaire executives at pharmaceutical companies, these are people with something to lose if threatened with jail. Frog-march them out of their door in suburbia, handcuffed and surrounded by DEA officers, with their children and neighbours watching.
By that time I was hooked on a career in academic research instead of one in the pharmaceutical industry that I had originally considered in deciding to get a PhD.
Drug companies say they need to charge ever-higher prices to cover their research costs, but they spend far less on research and development than they do on marketing and administration, and afterwards they actually keep more in profits.
We entered into the pharmaceutical industry in 1988, and since then, we have grown significantly on the back of a growing demand in India for pharmaceutical products.
Pharmaceutical companies have invested hundreds of millions of dollars in new HIV/AIDS treatments not out of altruism but because they can make up those research costs in sales.
Government leaders, researchers, physicians, the pharmaceutical industry, cancer advocates, and many other stakeholders all have a key role in promoting a safer, healthier environment, better nutrition, increased physical activity, and a new emphasis on prevention in cancer research.
Drug companies spend more on advertising and marketing than on research, more on research on lifestyle drugs than on life saving drugs, and almost nothing on diseases that affect developing countries only. This is not surprising. Poor people cannot afford drugs, and drug companies make investments that yield the highest returns.
We've had a long wrangle with the pharmaceutical industry about parallel imports, and what we were saying is we want to make medicines and drugs as affordable as a possible to what is largely a poor population.
We've grown from 18% of the profits of the top 25 companies in our industry to 23% of the profits of the top 25 companies in our industry over the last five years. Profits are up over 70%, where the industry profit is up about 35%. Pretty good.
This site uses cookies to ensure you get the best experience. More info...
Got it!